Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17320658 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Neoadjuvant Chemotherapy Plus Nephroureterectomy for Locally Advanced Upper Tract Transitional Cell Cancer
Condition: Transitional Cell Carcinoma
Interventions: Drug: Gemcitabine and cisplatin;   Other: Retrospective comparison

Indicates status has not been verified in more than two years